These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8792779)

  • 1. Estimating the dollar value of health outcomes from drug-abuse interventions.
    French MT; Mauskopf JA; Teague JL; Roland EJ
    Med Care; 1996 Sep; 34(9):890-910. PubMed ID: 8792779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conceptual framework for estimating the social cost of drug abuse.
    French MT; Rachal JV; Hubbard RL
    J Health Soc Policy; 1991; 2(3):1-22. PubMed ID: 10170913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the State of Washington.
    French MT; Salomé HJ; Carney M
    Soc Sci Med; 2002 Dec; 55(12):2267-82. PubMed ID: 12409139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the costs of substance abuse: implications to the estimation of the costs and benefits of gambling.
    Single E
    J Gambl Stud; 2003; 19(2):215-33. PubMed ID: 12766470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the value of avoiding morbidity and mortality from foodborne illnesses.
    Mauskopf JA; French MT
    Risk Anal; 1991 Dec; 11(4):619-31. PubMed ID: 1780502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for rapid estimation of the direct and indirect costs of HIV infection in a developing country.
    Over M; Bertozzi S; Chin J
    Health Policy; 1989; 11(2):169-86. PubMed ID: 10292983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost and cost-effectiveness of an enhanced intervention for people with substance abuse problems at risk for HIV.
    Zarkin GA; Lindrooth RC; Demiralp B; Wechsberg W
    Health Serv Res; 2001 Jun; 36(2):335-55. PubMed ID: 11409816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic costs of substance abuse, 1995.
    Rice DP
    Proc Assoc Am Physicians; 1999; 111(2):119-25. PubMed ID: 10220806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why we should still estimate the costs of substance abuse even if we needn't pay undue attention to the bottom line.
    Single E
    Drug Alcohol Rev; 2009 Mar; 28(2):117-21. PubMed ID: 19320695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs and benefits of combining probation and substance abuse treatment.
    Alemi F; Taxman F; Baghi H; Vang J; Thanner M; Doyon V
    J Ment Health Policy Econ; 2006 Jun; 9(2):57-70. PubMed ID: 17007484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the economic cost of substance abuse treatment.
    French MT; McGeary KA
    Health Econ; 1997; 6(5):539-44. PubMed ID: 9353658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating primary medical care with addiction treatment: a randomized controlled trial.
    Weisner C; Mertens J; Parthasarathy S; Moore C; Lu Y
    JAMA; 2001 Oct; 286(14):1715-23. PubMed ID: 11594896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost-effectiveness of substance abuse treatment.
    Barnett PG
    Curr Psychiatry Rep; 1999 Dec; 1(2):166-71. PubMed ID: 11122920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
    Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
    MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of the Social Costs of Illegal Drug Use in Poland Using Standardized Methodology.
    Mielecka-Kubie ZJ
    J Ment Health Policy Econ; 2020 Sep; 23(3):139-149. PubMed ID: 33411676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimates of economic costs of alcohol and drug abuse and mental illness, 1985 and 1988.
    Rice DP; Kelman S; Miller LS
    Public Health Rep; 1991; 106(3):280-92. PubMed ID: 1905049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valuing reduced antibiotic use for pediatric acute otitis media.
    Meropol SB
    Pediatrics; 2008 Apr; 121(4):669-73. PubMed ID: 18381529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.